Search Results 201-210 of 16130 for pharmacogenetics
Growth hormone is also used in adults to treat growth failure and to treat weight loss caused by acquired immunodeficiency syndrome (AIDS). This medicine is ...
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...
Global collaboration is needed to make sure that a new type of genetic test, the polygenic risk score, performs equitably among people from diverse groups.
Targeting cells. Dr. Barry's team engineers new ways to get genes into cells and amplify those genes and the proteins that they produce.
As genetic sequencing has become faster and cheaper, more people are considering predictive genetic testing to identify their future risk for disease, with the ...
About this study. The purpose of this study is to use whole genome sequencing to identify more causal pathways and variants responsible for hereditary ...
Peginesatide injection is used to treat anemia in patients with chronic kidney disease (CKD) who are on dialysis. This medicine was available only with your ...
Learn about how our experts use testing, genetic counseling and treatments to help people with a family history of heart disease at risk of heart attacks.
The primary purpose of the LTFU is to assess the long-term safety and tolerability of LX2006 up to 5 years post-treatment. Additionally, efficacy assessments ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.